Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Portal Vein Pressure 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 900Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Terlipressin × Clear all
NCT03352349 2017-11-24

Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection

Shanghai Zhongshan Hospital

Phase 2 Unknown
30 enrolled

Portal Vein Pressure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡